Last update Jan. 29, 2017
Very Low Risk
Synthetic drug analog to vitamin D3 which is similar to calcitriol.
It is topically used on the treatment of psoriasis.
At latest update relevant published data on excretion into breast milk were not found.
Due to a poor gut absorption, plasma levels were undetectable or very low (AEMPS 2014), so it is unlikely a passage in significant amounts into breastmilk.
In addition, it is a derivative of vitamin D3 with poor effect on calcium metabolism. No significant changes on calcium plasma levels have been observed, whenever compliance with the maximum recommended doses is followed (Murdoch 1992, Bourke 1993 and 1997, Blum 1998).
Therefore, several consensus of experts accept the use of Calcipotriol as safe while breastfeeding (Zip 2002, Leachman 2006, Strober 2009, Barrett 2013, Butler 2014) which can even be applied to the nipple whenever necessary (Barrett 2013 ).
It can be applied for long time periods during breastfeeding provided it would not cover more than 20% of body surface area (Barrett 2013).
It should be avoided application on the nipple of creams, gels and other topical containing-paraffin products (mineral oil) so that the infant would not absorb them (Noti 2003, Concin 2008).
In case of psoriasis of the nipple it should be applied after a feeding at breast followed by a thoroughly cleaning up with water before the next feeding.
We do not have alternatives for MC-903 since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.